ADMA Biologics Inc Research and Development Expenses 2013-2024 | ADMA

ADMA Biologics Inc research and development expenses from 2013 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
ADMA Biologics Inc Annual Research and Development Expenses
(Millions of US $)
2023 $3
2022 $4
2021 $4
2020 $6
2019 $2
2018 $4
2017 $6
2016 $8
2015 $7
2014 $10
2013 $9
2012 $3
ADMA Biologics Inc Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31 $0
2023-12-31 $0
2023-09-30 $1
2023-06-30 $1
2023-03-31 $1
2022-12-31 $1
2022-09-30 $1
2022-06-30 $1
2022-03-31 $1
2021-12-31 $1
2021-09-30 $1
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1
2020-09-30 $2
2020-06-30 $2
2020-03-31 $2
2019-12-31 $0
2019-09-30 $0
2019-06-30 $1
2019-03-31 $1
2018-12-31 $1
2018-09-30 $1
2018-06-30 $1
2018-03-31 $1
2017-12-31 $1
2017-09-30 $2
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $2
2016-06-30 $3
2016-03-31 $2
2015-12-31 $2
2015-09-30 $2
2015-06-30 $2
2015-03-31 $1
2014-12-31 $2
2014-09-30 $1
2014-06-30 $2
2014-03-31 $4
2013-12-31 $3
2013-09-30 $1
2013-06-30 $3
2013-03-31 $1
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.513B $0.258B
ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $167.808B 16.79
Vertex Pharmaceuticals (VRTX) United States $122.317B 31.47
Regeneron Pharmaceuticals (REGN) United States $117.806B 28.81
CSL (CSLLY) Australia $94.107B 0.00
Gilead Sciences (GILD) United States $86.350B 17.20
Bristol Myers Squibb (BMY) United States $86.152B 40.48
GSK (GSK) United Kingdom $80.557B 9.62
Moderna (MRNA) United States $46.928B 0.00
Biogen (BIIB) United States $32.681B 14.96
Alnylam Pharmaceuticals (ALNY) United States $31.012B 0.00
Argenex SE (ARGX) Netherlands $26.499B 0.00
BioNTech SE (BNTX) Germany $19.617B 165.04
Genmab (GMAB) Denmark $16.976B 19.90
Illumina (ILMN) United States $16.835B 120.09
BioMarin Pharmaceutical (BMRN) United States $16.187B 63.15
Sarepta Therapeutics (SRPT) United States $14.832B 1307.58
BeiGene (BGNE) Cayman Islands $14.032B 0.00
Incyte (INCY) United States $13.865B 21.44
Bio-Techne Corp (TECH) United States $11.362B 42.92
Insmed (INSM) United States $10.251B 0.00
QIAGEN (QGEN) Netherlands $9.295B 19.86
Legend Biotech (LEGN) United States $8.183B 0.00
Vaxcyte (PCVX) United States $8.165B 0.00
Exact Sciences (EXAS) United States $8.149B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Roivant Sciences (ROIV) United Kingdom $7.808B 0.00
Ascendis Pharma (ASND) Denmark $7.724B 0.00
Intra-Cellular Therapies (ITCI) United States $7.505B 0.00
Repligen (RGEN) United States $7.096B 92.70
Exelixis (EXEL) United States $6.786B 34.97
Halozyme Therapeutics (HALO) United States $6.618B 18.38
Blueprint Medicines (BPMC) United States $6.507B 0.00
Zealand Pharma (ZLDPF) Denmark $6.413B 0.00
Cytokinetics (CYTK) United States $5.426B 0.00
Viking Therapeutics (VKTX) United States $5.226B 0.00
Krystal Biotech (KRYS) United States $5.203B 0.00
Nuvalent (NUVL) United States $5.086B 0.00
Apellis Pharmaceuticals (APLS) United States $4.907B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.809B 0.00
ImmunityBio (IBRX) United States $4.682B 0.00
Alkermes (ALKS) Ireland $4.158B 16.27
Avidity Biosciences (RNA) United States $3.817B 0.00
Immunovant (IMVT) United States $3.806B 0.00
Axsome Therapeutics (AXSM) United States $3.663B 0.00
Guardant Health (GH) United States $3.596B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.369B 0.00
Merus (MRUS) Netherlands $3.345B 0.00
Denali Therapeutics (DNLI) United States $3.137B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.105B 0.00
Biohaven (BHVN) United States $3.092B 0.00
Amicus Therapeutics (FOLD) United States $2.873B 0.00
Arcellx (ACLX) United States $2.871B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.760B 0.00
Twist Bioscience (TWST) United States $2.706B 0.00
MorphoSys AG (MOR) Germany $2.704B 0.00
SpringWorks Therapeutics (SWTX) United States $2.683B 0.00
IDEAYA Biosciences (IDYA) United States $2.640B 0.00
Geron (GERN) United States $2.639B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.568B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.561B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.431B 0.00
Celldex Therapeutics (CLDX) United States $2.380B 0.00
Iovance Biotherapeutics (IOVA) United States $2.269B 0.00
Certara (CERT) United States $2.242B 51.63
Apogee Therapeutics (APGE) United States $2.236B 0.00
Myriad Genetics (MYGN) United States $2.228B 0.00
Vericel (VCEL) United States $2.224B 0.00
Intellia Therapeutics (NTLA) United States $2.210B 0.00
Janux Therapeutics (JANX) United States $2.064B 0.00
Bavarian Nordic (BVNRY) Denmark $2.048B 8.92
Beam Therapeutics (BEAM) United States $2.045B 0.00
CG Oncology (CGON) United States $2.034B 0.00
Fortrea Holdings (FTRE) United States $2.028B 24.92
Rocket Pharmaceuticals (RCKT) United States $1.933B 0.00
Protagonist Therapeutics (PTGX) United States $1.863B 13.02
Vera Therapeutics (VERA) United States $1.845B 0.00
Novavax (NVAX) United States $1.841B 0.00
Kymera Therapeutics (KYMR) United States $1.834B 0.00
Zai Lab (ZLAB) China $1.783B 0.00
Arvinas (ARVN) United States $1.770B 0.00
Structure Therapeutics (GPCR) United States $1.766B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.765B 13.45
Immunocore Holdings (IMCR) United Kingdom $1.699B 0.00
NeoGenomics (NEO) United States $1.696B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.690B 0.00
Galapagos (GLPG) Belgium $1.657B 0.00
Keros Therapeutics (KROS) United States $1.644B 0.00
Edgewise Therapeutics (EWTX) United States $1.633B 0.00
Morphic Holding (MORF) United States $1.626B 0.00
Akero Therapeutics (AKRO) United States $1.586B 0.00
Kura Oncology (KURA) United States $1.569B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.549B 0.00
Dynavax Technologies (DVAX) United States $1.442B 183.67
Belite Bio (BLTE) United States $1.421B 0.00
MannKind (MNKD) United States $1.413B 173.00
Ligand Pharmaceuticals (LGND) United States $1.401B 22.89
Arcus Biosciences (RCUS) United States $1.379B 0.00
ANI Pharmaceuticals (ANIP) United States $1.373B 17.06
Neumora Therapeutics (NMRA) United States $1.372B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.315B 0.00
Vir Biotechnology (VIR) United States $1.238B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.187B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.175B 0.00
Sana Biotechnology (SANA) United States $1.163B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.075B 0.00
Prothena (PRTA) Ireland $1.073B 0.00
Disc Medicine (IRON) United States $1.073B 0.00
Nurix Therapeutics (NRIX) United States $1.006B 0.00
Immatics (IMTX) Germany $1.001B 0.00
MiMedx (MDXG) United States $0.985B 41.69
Tarsus Pharmaceuticals (TARS) United States $0.954B 0.00
Cullinan Therapeutics (CGEM) United States $0.951B 0.00
Tango Therapeutics (TNGX) United States $0.948B 0.00
Spyre Therapeutics (SYRE) United States $0.942B 0.00
Liquidia Technologies (LQDA) United States $0.941B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.894B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.865B 0.00
Tyra Biosciences (TYRA) United States $0.830B 0.00
Rapport Therapeutics (RAPP) $0.823B 0.00
AbCellera Biologics (ABCL) Canada $0.820B 0.00
Abivax SA (ABVX) France $0.816B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.803B 0.00
Gyre Therapeutics (GYRE) United States $0.800B 0.00
Viridian Therapeutics (VRDN) United States $0.786B 0.00
Cogent Biosciences (COGT) United States $0.774B 0.00
Mesoblast (MESO) Australia $0.758B 0.00
CureVac (CVAC) Germany $0.753B 0.00
Nuvation Bio (NUVB) United States $0.739B 0.00
Immunome (IMNM) United States $0.721B 0.00
89BIO (ETNB) United States $0.719B 0.00
Tectonic Therapeutic (TECX) United States $0.715B 0.00
Cytek Biosciences (CTKB) United States $0.696B 0.00
Dianthus Therapeutics (DNTH) United States $0.695B 0.00
Praxis Precision Medicines (PRAX) United States $0.692B 0.00
Stoke Therapeutics (STOK) United States $0.673B 0.00
AnaptysBio (ANAB) United States $0.662B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.659B 0.00
HilleVax (HLVX) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
PureTech Health (PRTC) United States $0.644B 0.00
Pliant Therapeutics (PLRX) United States $0.638B 0.00
Travere Therapeutics (TVTX) United States $0.628B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.628B 0.00
Scholar Rock Holding (SRRK) United States $0.625B 0.00
Olema Pharmaceuticals (OLMA) United States $0.619B 0.00
Prime Medicine (PRME) United States $0.609B 0.00
Pharming Group (PHGUF) Netherlands $0.606B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.598B 0.00
GH Research (GHRS) Ireland $0.596B 0.00
Humacyte (HUMA) United States $0.595B 0.00
Zymeworks (ZYME) United States $0.594B 0.00
Castle Biosciences (CSTL) United States $0.582B 0.00
CARGO Therapeutics (CRGX) United States $0.575B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Arbutus Biopharma (ABUS) United States $0.568B 0.00
ArriVent BioPharma (AVBP) United States $0.568B 0.00
REGENXBIO (RGNX) United States $0.567B 0.00
Celcuity (CELC) United States $0.563B 0.00
Mineralys Therapeutics (MLYS) United States $0.551B 0.00
PepGen (PEPG) United States $0.549B 0.00
Northwest Biotherapeutics (NWBO) United States $0.547B 0.00
Pharming Group (PHAR) Netherlands $0.545B 0.00
ITeos Therapeutics (ITOS) United States $0.543B 0.00
WAVE Life Sciences (WVE) Singapore $0.536B 0.00
Contineum Therapeutics (CTNM) United States $0.535B 0.00
Replimune (REPL) United States $0.535B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.528B 0.00
Third Harmonic Bio (THRD) United States $0.514B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.511B 0.00
Applied Therapeutics (APLT) United States $0.510B 0.00
Adaptive Biotechnologies (ADPT) United States $0.503B 0.00
Astria Therapeutics (ATXS) United States $0.494B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.490B 0.00
Allogene Therapeutics (ALLO) United States $0.489B 0.00
Oculis Holding AG (OCS) Switzerland $0.480B 0.00
Entrada Therapeutics (TRDA) United States $0.476B 22.38
Oric Pharmaceuticals (ORIC) United States $0.447B 0.00
Avid Bioservices (CDMO) United States $0.445B 0.00
Cartesian Therapeutics (RNAC) United States $0.440B 0.00
Terns Pharmaceuticals (TERN) United States $0.431B 0.00
Annexon (ANNX) United States $0.430B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.427B 0.00
Voyager Therapeutics (VYGR) United States $0.424B 0.00
Alector (ALEC) United States $0.416B 0.00
Neurogene (NGNE) United States $0.416B 0.00
MaxCyte (MXCT) United States $0.415B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.414B 0.00
Urogen Pharma (URGN) United States $0.403B 0.00
Editas Medicine (EDIT) United States $0.396B 0.00
IGM Biosciences (IGMS) United States $0.395B 0.00
AC Immune (ACIU) Switzerland $0.393B 0.00
Precigen (PGEN) United States $0.391B 0.00
Fulcrum Therapeutics (FULC) United States $0.383B 0.00
ACELYRIN, INC (SLRN) United States $0.382B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.382B 0.00
Erasca (ERAS) United States $0.381B 0.00
Anika Therapeutics (ANIK) United States $0.374B 320.62
Fate Therapeutics (FATE) United States $0.371B 0.00
EnGene Holdings (ENGN) United States $0.353B 0.00
Aura Biosciences (AURA) United States $0.353B 0.00
Cabaletta Bio (CABA) United States $0.350B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.348B 0.00
Absci (ABSI) United States $0.347B 0.00
Emergent Biosolutions (EBS) United States $0.344B 0.00
Ocugen (OCGN) United States $0.329B 0.00
Anavex Life Sciences (AVXL) United States $0.323B 0.00
TScan Therapeutics (TCRX) United States $0.323B 0.00
C4 Therapeutics (CCCC) United States $0.319B 0.00
Jasper Therapeutics (JSPR) United States $0.316B 0.00
Kyverna Therapeutics (KYTX) United States $0.313B 0.00
ALX Oncology Holdings (ALXO) United States $0.306B 0.00
Agenus (AGEN) United States $0.298B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.295B 0.00
Nkarta (NKTX) United States $0.295B 0.00
Alimera Sciences (ALIM) United States $0.289B 0.00
Kamada (KMDA) Israel $0.287B 21.74
Amarin (AMRN) Ireland $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.284B 0.00
Nautilus Biotechnology (NAUT) United States $0.278B 0.00
Inozyme Pharma (INZY) United States $0.273B 0.00
Scilex Holding (SCLX) United States $0.272B 0.00
MeiraGTx Holdings (MGTX) United States $0.271B 0.00
Molecular Partners AG (MOLN) Switzerland $0.268B 0.00
Alto Neuroscience (ANRO) United States $0.268B 0.00
XOMA (XOMA) United States $0.263B 0.00
Mersana Therapeutics (MRSN) United States $0.247B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.246B 0.00
Revance Therapeutics (RVNC) United States $0.244B 0.00
Prima BioMed (IMMP) Australia $0.244B 0.00
Sutro Biopharma (STRO) United States $0.240B 0.00
Poseida Therapeutics (PSTX) United States $0.239B 0.00
Renovaro (RENB) United States $0.232B 0.00
CorMedix Inc (CRMD) United States $0.228B 0.00
Codexis (CDXS) United States $0.224B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.223B 0.00
Greenwich LifeSciences (GLSI) United States $0.220B 0.00
Solid Biosciences (SLDB) United States $0.219B 0.00
Skye Bioscience (SKYE) United States $0.215B 0.00
UniQure (QURE) Netherlands $0.214B 0.00
Tenaya Therapeutics (TNYA) United States $0.214B 0.00
Gossamer Bio (GOSS) United States $0.212B 0.00
Inhibrx Biosciences (INBX) $0.212B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.205B 0.00
Inovio Pharmaceuticals (INO) United States $0.202B 0.00
ChromaDex (CDXC) United States $0.202B 0.00
23andMe Holding (ME) United States $0.197B 0.00
Rani Therapeutics Holdings (RANI) United States $0.196B 0.00
Coherus BioSciences (CHRS) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.187B 0.00
Trevi Therapeutics (TRVI) United States $0.187B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.186B 0.00
Q32 Bio (QTTB) United States $0.185B 0.00
2seventy Bio (TSVT) United States $0.185B 0.00
Design Therapeutics (DSGN) United States $0.182B 0.00
Shattuck Labs (STTK) United States $0.180B 0.00
Adocia (ADOCY) France $0.174B 0.00
Candel Therapeutics (CADL) United States $0.170B 0.00
X4 Pharmaceuticals (XFOR) United States $0.168B 0.00
Abeona Therapeutics (ABEO) United States $0.168B 0.00
Oncobiologics (OTLK) United States $0.167B 0.00
Ventyx Biosciences (VTYX) United States $0.164B 0.00
Innate Pharma S.A (IPHA) France $0.163B 0.00
Rezolute (RZLT) United States $0.161B 0.00
ScPharmaceuticals (SCPH) United States $0.160B 0.00
Biomea Fusion (BMEA) United States $0.160B 0.00
Inventiva S.A (IVA) France $0.157B 0.00
BioStem Technologies (BSEM) $0.153B 0.00
Syros Pharmaceuticals (SYRS) United States $0.152B 0.00
Compugen (CGEN) Israel $0.152B 0.00
Puma Biotechnology (PBYI) United States $0.151B 9.52
XBiotech (XBIT) United States $0.149B 0.00
FibroBiologics (FBLG) United States $0.147B 0.00
Lifecore Biomedical (LFCR) United States $0.146B 0.00
Caribou Biosciences (CRBU) United States $0.146B 0.00
Compass Therapeutics (CMPX) United States $0.146B 0.00
Adverum Biotechnologies (ADVM) United States $0.145B 0.00
Invivyd (IVVD) United States $0.144B 0.00
INmune Bio (INMB) United States $0.144B 0.00
Repare Therapeutics (RPTX) Canada $0.143B 0.00
Zura Bio (ZURA) United States $0.143B 0.00
Vigil Neuroscience (VIGL) United States $0.142B 0.00
I-Mab (IMAB) China $0.138B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.134B 0.00
Adagene (ADAG) China $0.132B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.130B 0.00
Omega Therapeutics (OMGA) United States $0.130B 0.00
Adlai Nortye (ANL) Cayman Islands $0.129B 0.00
Elevation Oncology (ELEV) United States $0.128B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Akoya Biosciences (AKYA) United States $0.127B 0.00
Semper Paratus Acquisition (TVGN) United States $0.125B 0.00
Kodiak Sciences (KOD) United States $0.120B 0.00
Sagimet Biosciences (SGMT) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.119B 0.00
G1 Therapeutics (GTHX) United States $0.118B 0.00
Seres Therapeutics (MCRB) United States $0.114B 0.00
CervoMed (CRVO) United States $0.114B 0.00
DiaMedica Therapeutics (DMAC) United States $0.112B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.112B 0.00
PDS Biotechnology (PDSB) United States $0.112B 0.00
Adicet Bio (ACET) United States $0.110B 0.00
Opthea (OPT) Australia $0.110B 0.00
Seer (SEER) United States $0.108B 0.00
Rapt Therapeutics (RAPT) United States $0.106B 0.00
ATyr Pharma (ATYR) United States $0.106B 0.00
Cardiff Oncology (CRDF) United States $0.105B 0.00
Cellectis S.A (CLLS) France $0.104B 0.00
BioHarvest Sciences (CNVCD) Canada $0.102B 0.00
Werewolf Therapeutics (HOWL) United States $0.102B 0.00
Bluebird Bio (BLUE) United States $0.099B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.096B 0.00
BeyondSpring (BYSI) United States $0.095B 0.00
CytomX Therapeutics (CTMX) United States $0.094B 6.05
InflaRx (IFRX) Germany $0.094B 0.00
Allakos (ALLK) United States $0.094B 0.00
Athira Pharma (ATHA) United States $0.092B 0.00
DBV Technologies S.A (DBVT) France $0.091B 0.00
Clearside Biomedical (CLSD) United States $0.090B 0.00
Boundless Bio (BOLD) United States $0.089B 0.00
Immunic (IMUX) United States $0.088B 0.00
Sangamo Therapeutics (SGMO) United States $0.088B 0.00
VistaGen Therapeutics (VTGN) United States $0.088B 0.00
Coya Therapeutics (COYA) United States $0.088B 0.00
Eton Pharmaceuticals (ETON) United States $0.086B 84.00
Elutia (ELUT) United States $0.086B 0.00
Affimed (AFMD) Germany $0.085B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
Ikena Oncology (IKNA) United States $0.079B 0.00
Vor Biopharma (VOR) $0.079B 0.00
Verastem (VSTM) United States $0.078B 0.00
IO Biotech (IOBT) Denmark $0.078B 0.00
Gritstone Bio (GRTS) United States $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
China Health Industries Holdings (CHHE) China $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.074B 0.00
Genelux (GNLX) United States $0.074B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.073B 0.00
Connect Biopharma Holdings (CNTB) United States $0.073B 0.00
Spero Therapeutics (SPRO) United States $0.072B 2.61
Milestone Pharmaceuticals (MIST) Canada $0.071B 0.00
Theratechnologies (THTX) Canada $0.071B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.069B 0.00
Earth Science Tech (ETST) United States $0.068B 0.00
Cognition Therapeutics (CGTX) United States $0.068B 0.00
Entera Bio (ENTX) Israel $0.068B 0.00
BioAtla (BCAB) United States $0.068B 0.00
Intensity Therapeutics (INTS) United States $0.068B 0.00
Cue Biopharma (CUE) United States $0.067B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.067B 0.00
Elicio Therapeutics (ELTX) United States $0.066B 0.00
Galena Biopharma (SLS) United States $0.065B 0.00
Annovis Bio (ANVS) United States $0.064B 0.00
HOOKIPA Pharma (HOOK) United States $0.063B 0.00
Instil Bio (TIL) United States $0.063B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.063B 0.00
AN2 Therapeutics (ANTX) United States $0.063B 0.00
Benitec Biopharma (BNTC) United States $0.063B 0.00
Aileron Therapeutics (ALRN) United States $0.063B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.062B 0.00
LENZ Therapeutics (LENZ) United States $0.062B 0.00
Genenta Science S.p.A (GNTA) Italy $0.061B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Rallybio (RLYB) United States $0.058B 0.00
Celularity (CELU) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.057B 0.00
LakeShore Biopharma (LSB) China $0.057B 0.00
Passage Bio (PASG) United States $0.056B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.056B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.053B 0.00
Alpha Teknova (TKNO) United States $0.053B 0.00
Cidara Therapeutics (CDTX) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Ovid Therapeutics (OVID) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
CalciMedica (CALC) United States $0.050B 0.00
Dyadic (DYAI) United States $0.050B 0.00
BioXcel Therapeutics (BTAI) United States $0.050B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.048B 0.00
Ocean Biomedical (OCEA) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.046B 0.00
Lantern Pharma (LTRN) United States $0.046B 0.00
Clene (CLNN) United States $0.045B 0.00
Leap Therapeutics (LPTX) United States $0.045B 0.00
NextCure (NXTC) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
Dare Bioscience (DARE) United States $0.044B 0.00
Aerovate Therapeutics (AVTE) United States $0.042B 0.00
Immuneering (IMRX) United States $0.041B 0.00
Ocuphire Pharma (OCUP) United States $0.040B 0.00
Aadi Bioscience (AADI) United States $0.039B 0.00
IN8bio (INAB) United States $0.039B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.035B 0.00
Atara Biotherapeutics (ATRA) United States $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.035B 0.00
OKYO Pharma (OKYO) $0.034B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
NKGen Biotech (NKGN) United States $0.032B 0.00
Aligos Therapeutics (ALGS) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Quince Therapeutics (QNCX) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Lisata Therapeutics (LSTA) United States $0.028B 0.00
HCW Biologics (HCWB) United States $0.028B 0.00
Bolt Biotherapeutics (BOLT) United States $0.028B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
Cocrystal Pharma (COCP) United States $0.025B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.024B 0.00
Equillium (EQ) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Carmell (CTCX) United States $0.023B 0.00
Biora Therapeutics (BIOR) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
BioAffinity Technologies (BIAF) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Orgenesis (ORGS) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Lumos Pharma (LUMO) United States $0.018B 0.00
Kintara Therapeutics (KTRA) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Apollomics (APLM) United States $0.018B 0.00
Forte Biosciences (FBRX) United States $0.017B 0.00
Vincerx Pharma (VINC) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Sensei Biotherapeutics (SNSE) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
Galecto (GLTO) Denmark $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.013B 0.00
KALA BIO (KALA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.012B 0.00
Chemomab Therapeutics (CMMB) Israel $0.011B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Longeveron (LGVN) United States $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
AEterna Zentaris (AEZS) Canada $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.006B 0.00
Genetic Technologies (GENE) Australia $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
TFF Pharmaceuticals (TFFP) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
GeoVax Labs (GOVX) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Entero Therapeutics (ENTO) United States $0.004B 0.00
Trevena (TRVN) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.42
NexImmune (NEXI) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cingulate (CING) United States $0.003B 0.00
Novogen (KZIA) Australia $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Psyence Biomedical (PBM) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Soligenix (SNGX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Notable Labs (NTBL) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
CNS Pharmaceuticals (CNSP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00